# Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

> **NCT06677775** · — · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06677775
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-30
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06677775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06677775, "Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06677775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*